| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |